Bangkok Chain Hospital Public Company (BCH) Fair Value & Analysis
Healthcare · TH · Market cap 23.1B THB
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Share price +5.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 8.51 THB – 13.13 THB · fair‑value band 8.58 THB – 14.52 THB · the 9.35 THB price screens below the 11.61 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Bangkok Chain Hospital Public Company (BCH) currently trades at 9.35 THB, while our model-based Fair Value estimate is 11.61 THB — implying the stock looks roughly 24.2% undervalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Bangkok Chain Hospital Public Company generated revenue of 12.0B THB at a net margin of 10.5%. It earns a return on equity of 9.5%. The balance sheet holds a net cash position of 705M THB. The stock trades on a trailing P/E of 18.1. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Bangkok Chain Hospital Public Company Limited, together with its subsidiaries, operates private hospitals in Bangkok vicinity, Chiang Rai, Saraburi, Nonthaburi, Pathumthani, Ayudhaya, Chachoengsao, Prachinburi, Sa Kaeo Province, and Lao People's Democratic Republic. It offers diagnosis, treatment, prevention, rehabilitation services for heart disease; open heart surgery to provide heart care and clinical treatment by cardiologists; and medical supports. The company also operates diagnostic imaging centers; eye centers that provide eye examination, treatment, and surgery services; cancer centers that offer services ranging from screening, diagnosis, and chemotherapy; fertility centers for infertility treatment, as well as diabetic wound treatment centers. In addition, the company sells health-related drinks; provides medical analysis and research services; and develops package computer programs. The company was founded in 1984 and is headquartered in Nonthaburi, Thailand.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Bangkok Chain Hospital Public Company reported revenue of 11.9B THB in FY2025 versus 21.4B THB in FY2021, a compound −13.6%/yr. Reported net income was 1.3B THB in FY2025, compounding −33.8%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| 5225 5225 | 8.67 MYR | 3.08 MYR | -64% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Bangkok Chain Hospital Public Company (BCH) undervalued?
What is the fair value of BCH?
What is the quality score of BCH?
What is the revenue of Bangkok Chain Hospital Public Company (BCH)?
What is the net profit margin of BCH?
Does Bangkok Chain Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.